Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Groen

Showing results (441-450 of 456) with videos related to

Pageof 46
Sort By:
Neurosurgery|February 26, 2015
Time course and risk factors for myocardial dysfunction after aneurysmal subarachnoid hemorrhageIvo A van der Bilt, Djo Hasan, Renee B van den Brink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with DaratumumabJakub Krejcik, Kris A Frerichs, Inger S Nijhof, et al.
Blood|June 2, 2012
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaRichard W J Groen, Willy A Noort, Reinier A Raymakers, et al.
Science Translational Medicine|December 8, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistenceAfroditi Katsarou, Maria Sjöstrand, Jyoti Naik, et al.
Journal for Immunotherapy of Cancer|June 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener studyKarlijn de Joode, Harry J Groen, Michel van den Heuvel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> MutationsChristian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
Breast Cancer Research and Treatment|August 1, 2020
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability studyEmma J Groen, Jan Hudecek, Lennart Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2025
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome databaseChristian Menzer, Susanne Dugas-Breit, Martin Dugas, et al.
BMJ Open|November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort studyGwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic TherapyVincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, et al.
Pageof 46

Showing results (441-450 of 456) with videos related to

Sort By:
Pageof 46
Neurosurgery|February 26, 2015
Time course and risk factors for myocardial dysfunction after aneurysmal subarachnoid hemorrhageIvo A van der Bilt, Djo Hasan, Renee B van den Brink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with DaratumumabJakub Krejcik, Kris A Frerichs, Inger S Nijhof, et al.
Blood|June 2, 2012
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaRichard W J Groen, Willy A Noort, Reinier A Raymakers, et al.
Science Translational Medicine|December 8, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistenceAfroditi Katsarou, Maria Sjöstrand, Jyoti Naik, et al.
Journal for Immunotherapy of Cancer|June 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener studyKarlijn de Joode, Harry J Groen, Michel van den Heuvel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> MutationsChristian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
Breast Cancer Research and Treatment|August 1, 2020
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability studyEmma J Groen, Jan Hudecek, Lennart Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2025
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome databaseChristian Menzer, Susanne Dugas-Breit, Martin Dugas, et al.
BMJ Open|November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort studyGwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic TherapyVincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, et al.
Pageof 46